Federal contract award

36C25225C0011

DR VEMUGHANTI - METHYLATED AND HYDROXYMETHYLATED DNA IMMUNOPRECIPITATION SEQUENCING

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Veterans Affairs
Office252-NETWORK CONTRACT OFFICE 12 (36C252)
NAICS541714 — Research and Development in Biotechnology (except Nanobiotechnology)
PSCAN11 — HEALTH R&D SERVICES; HEALTH CARE SERVICES; BASIC RESEARCH
Parent award / vehicleNot reported
Set-asideNO SET ASIDE USED.
Pricing typeFIRM FIXED PRICE
Obligations$77.7K
Current contract value$77.7K
Potential contract value / ceiling$77.7K
Start dateMar 1, 2025
Current end dateAug 31, 2025
Potential end dateAug 31, 2025
Latest award activityJun 18, 2025
Source loadedAug 15, 2026

Funding and modification history

Showing the latest 2 of 2 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jun 18, 2025P00001$25.2KDR VEMUGHANTI - METHYLATED AND HYDROXYMETHYLATED DNA IMMUNOPRECIPITATION SEQUENCING
Feb 3, 20250$52.5KDR VEMUGHANTI - METHYLATED AND HYDROXYMETHYLATED DNA IMMUNOPRECIPITATION SEQUENCING

Buyer contacts from matching notices

Matched on exact award/solicitation identifier and awarding agency. Source dates describe the notice, not current contact verification.

ContactRolePublished contact methodsEvidenceSource date
Michael M HrdiContract Specialistmichael.hrdi@va.gov
414-844-4800 x43249
SourceNov 25, 2024

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.